Title: 3 SENATE BILL NO. 518 By: Alvord of the Senate
Official Title: 3 SENATE BILL NO. 518 By: Alvord of the Senate
Number of Sections: 1
Source: versions - Floor (Senate)
Media Type: application/pdf
Strikethrough Detection: 4 sections found

================================================================================

Section 1:
1 SENATE FLOOR VERSION
February 13, 2025
2
4 and
5 West (Kevin) of the House
6
7
8 An Act relating to medical marijuana packaging;
amending 63 O.S. 2021, Section 427.18, as last
9 amended by Section 144, Chapter 452, O.S.L. 2024 (63
O.S. Supp. 2024, Section 427.18), which relates to
10 packaging and labeling requirements; requiring
certain labeling; and providing an effective date.
11
12
13 BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA:
14 SECTION 1. AMENDATORY 63 O.S. 2021, Section 427.18, as
15 last amended by Section 144, Chapter 452, O.S.L. 2024 (63 O.S. Supp.
16 2024, Section 427.18), is amended to read as follows:
17 Section 427.18. A. A medical marijuana business shall not
18 sell, transfer or otherwise distribute medical marijuana or medical
19 marijuana product that has not been packaged and labeled in
20 accordance with this section and rules promulgated by the Executive
21 Director of the Oklahoma Medical Marijuana Authority.
22 B. A medical marijuana dispensary shall return medical
23 marijuana and medical marijuana product that does not meet packaging
24 or labeling requirements in this section or rules promulgated
SENATE FLOOR VERSION - SB518 SFLR Page 1
(Bold face denotes Committee Amendments)
1 purs uant thereto to the entity who transferred it to the dispensary.
2 The medical marijuana dispensary shall document to whom the item was
3 returned, what was returned, and the date of the return, or dispose
4 of any usable marijuana that does not meet these requirements in
5 accordance with the Oklahoma Medical Marijuana and Patient
6 Protection Act.
7 C. 1. Medical marijuana packaging shall be packaged to
8 minimize its appeal to children and shall not depict images other
9 than the business name logo of the medical marijuana producer and
10 image of the product.
11 2. A medical marijuana business shall not place any content on
12 a container in a manner that reasonably appears to target
13 individuals under the age of twenty-one (21) including, but not
14 limited to, cartoon characters or similar images.
15 3. Labels on a container shall not include any false or
16 misleading statements.
17 4. No container shall be intentionally or knowingly labeled so
18 as to cause a reasonable patient confusion as to whether the medical
19 marijuana, medical marijuana concentrate or medical marijuana
20 product is a trademarked product or labeled in a manner that
21 violates any federal trademark law or regulation. The label on the
22 container shall include a warning that states the following:
23 a. “For use by licensed medical marijuana patients only”,
24 and
SENATE FLOOR VERSION - SB518 SFLR Page 2
(Bold face denotes Committee Amendments)
1 b. “Keep out of reach of children”., and
2 c. “Marijuana and marijuana products can impair
3 concentration, coordination, and judgment: a person
4 should not operate a motor vehicle while under the
5 influence of marijuana or marijuana products. The
6 ingestion of any amount of marijuana or marijuana
7 products before driving may result in criminal
8 prosecution for driving under the influence.”
9 5. The label on the container shall not make any claims
10 regarding health or physical benefits to the patient.
11 6. The container itself may be clear in order to allow licensed
12 medical marijuana patients and licensed medical marijuana caregivers
13 the ability to view the product inside the container but shall be
14 child-resistant, as defined in Section 427.2 of this title.
15 7. At the point of sale and transfer of any medical marijuana,
16 medical marijuana concentrate, or medical marijuana products to a
17 licensed medical marijuana patient or licensed medical marijuana
18 caregiver, the dispensary shall place the medical marijuana, medical
19 marijuana concentrate, or medical marijuana products in an exit
20 package, as such term is defined in Section 427.2 of this title.
21 D. The Executive Director shall develop minimum standards for
22 packaging and labeling of medical marijuana, medical marijuana
23 concentrate, and medical marijuana products. Such standards shall
24 include, but not be limited to, the required contents of labels to
SENATE FLOOR VERSION - SB518 SFLR Page 3
(Bold face denotes Committee Amendments)
1 be a ffixed to all medical marijuana, medical marijuana concentrate,
2 and medical marijuana products prior to transfer to a licensed
3 patient or caregiver, which shall include, at a minimum:
4 1. THC and other cannabinoid potency, and terpenoid potency;
5 2. A statement indicating that the product has been tested for
6 contaminants;
7 3. One or more product warnings to be determined by the
8 Executive Director; and
9 4. Any other information the Executive Director deems
10 necessary.
11 SECTION 2. This act shall become effective November 1, 2025.
12 COMMITTEE REPORT BY: COMMITTEE ON BUSINESS AND INSURANCE
February 13, 2025 - DO PASS
13
14
15
16
17
18
19
20
21
22
23
24
SENATE FLOOR VERSION - SB518 SFLR Page 4
(Bold face denotes Committee Amendments)
[DELETED: P B A  a W]
[DELETED: P “]
[DELETED: P “ “]
[DELETED: P]


================================================================================

Raw Text:
1 SENATE FLOOR VERSION
February 13, 2025
2
3 SENATE BILL NO. 518 By: Alvord of the Senate
4 and
5 West (Kevin) of the House
6
7
8 An Act relating to medical marijuana packaging;
amending 63 O.S. 2021, Section 427.18, as last
9 amended by Section 144, Chapter 452, O.S.L. 2024 (63
O.S. Supp. 2024, Section 427.18), which relates to
10 packaging and labeling requirements; requiring
certain labeling; and providing an effective date.
11
12
13 BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA:
14 SECTION 1. AMENDATORY 63 O.S. 2021, Section 427.18, as
15 last amended by Section 144, Chapter 452, O.S.L. 2024 (63 O.S. Supp.
16 2024, Section 427.18), is amended to read as follows:
17 Section 427.18. A. A medical marijuana business shall not
18 sell, transfer or otherwise distribute medical marijuana or medical
19 marijuana product that has not been packaged and labeled in
20 accordance with this section and rules promulgated by the Executive
21 Director of the Oklahoma Medical Marijuana Authority.
22 B. A medical marijuana dispensary shall return medical
23 marijuana and medical marijuana product that does not meet packaging
24 or labeling requirements in this section or rules promulgated
SENATE FLOOR VERSION - SB518 SFLR Page 1
(Bold face denotes Committee Amendments)

1 purs uant thereto to the entity who transferred it to the dispensary.
2 The medical marijuana dispensary shall document to whom the item was
3 returned, what was returned, and the date of the return, or dispose
4 of any usable marijuana that does not meet these requirements in
5 accordance with the Oklahoma Medical Marijuana and Patient
6 Protection Act.
7 C. 1. Medical marijuana packaging shall be packaged to
8 minimize its appeal to children and shall not depict images other
9 than the business name logo of the medical marijuana producer and
10 image of the product.
11 2. A medical marijuana business shall not place any content on
12 a container in a manner that reasonably appears to target
13 individuals under the age of twenty-one (21) including, but not
14 limited to, cartoon characters or similar images.
15 3. Labels on a container shall not include any false or
16 misleading statements.
17 4. No container shall be intentionally or knowingly labeled so
18 as to cause a reasonable patient confusion as to whether the medical
19 marijuana, medical marijuana concentrate or medical marijuana
20 product is a trademarked product or labeled in a manner that
21 violates any federal trademark law or regulation. The label on the
22 container shall include a warning that states the following:
23 a. “For use by licensed medical marijuana patients only”,
24 and
SENATE FLOOR VERSION - SB518 SFLR Page 2
(Bold face denotes Committee Amendments)

1 b. “Keep out of reach of children”., and
2 c. “Marijuana and marijuana products can impair
3 concentration, coordination, and judgment: a person
4 should not operate a motor vehicle while under the
5 influence of marijuana or marijuana products. The
6 ingestion of any amount of marijuana or marijuana
7 products before driving may result in criminal
8 prosecution for driving under the influence.”
9 5. The label on the container shall not make any claims
10 regarding health or physical benefits to the patient.
11 6. The container itself may be clear in order to allow licensed
12 medical marijuana patients and licensed medical marijuana caregivers
13 the ability to view the product inside the container but shall be
14 child-resistant, as defined in Section 427.2 of this title.
15 7. At the point of sale and transfer of any medical marijuana,
16 medical marijuana concentrate, or medical marijuana products to a
17 licensed medical marijuana patient or licensed medical marijuana
18 caregiver, the dispensary shall place the medical marijuana, medical
19 marijuana concentrate, or medical marijuana products in an exit
20 package, as such term is defined in Section 427.2 of this title.
21 D. The Executive Director shall develop minimum standards for
22 packaging and labeling of medical marijuana, medical marijuana
23 concentrate, and medical marijuana products. Such standards shall
24 include, but not be limited to, the required contents of labels to
SENATE FLOOR VERSION - SB518 SFLR Page 3
(Bold face denotes Committee Amendments)

1 be a ffixed to all medical marijuana, medical marijuana concentrate,
2 and medical marijuana products prior to transfer to a licensed
3 patient or caregiver, which shall include, at a minimum:
4 1. THC and other cannabinoid potency, and terpenoid potency;
5 2. A statement indicating that the product has been tested for
6 contaminants;
7 3. One or more product warnings to be determined by the
8 Executive Director; and
9 4. Any other information the Executive Director deems
10 necessary.
11 SECTION 2. This act shall become effective November 1, 2025.
12 COMMITTEE REPORT BY: COMMITTEE ON BUSINESS AND INSURANCE
February 13, 2025 - DO PASS
13
14
15
16
17
18
19
20
21
22
23
24
SENATE FLOOR VERSION - SB518 SFLR Page 4
(Bold face denotes Committee Amendments)

[DELETED: P B A  a W]
[DELETED: P “]
[DELETED: P “ “]
[DELETED: P]